Obsessive-Compulsive Disorder

• 

  Subject Areas on Research

  • A comparison between the growth hormone responses to amphetamine and clonidine. 
  • A double-blind combination study of clonazepam with sertraline in obsessive-compulsive disorder. 
  • A follow-up study of post partum illness, 1946-1978. 
  • A longitudinal examination of the psychoeducational, neurocognitive, and psychiatric functioning in children with 22q11.2 deletion syndrome. 
  • A longitudinal study of neurosis in young men. 
  • Acceptability, feasibility, and efficacy of Internet cognitive behavioral therapy (iCBT) for pediatric obsessive-compulsive disorder: a systematic review. 
  • Altered fronto-amygdalar functional connectivity predicts response to cognitive behavioral therapy in pediatric obsessive-compulsive disorder. 
  • Altered network connectivity predicts response to cognitive-behavioral therapy in pediatric obsessive-compulsive disorder. 
  • An obsessional variant of capgras symptom: a case report. 
  • Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive-compulsive disorder. 
  • Assessing Acute Secondary Treatment Outcomes in Early-Onset Obsessive-Compulsive Disorder. 
  • Behavioral treatment of obsessive-compulsive neurosis. 
  • Belief in life after death and mental health: findings from a national survey. 
  • Center stage for the serotonin transporter: a gain-of-function polymorphism in persons with obsessive-compulsive disorder. 
  • Characteristics associated with presence of depressive symptoms in adults with autism spectrum disorder. 
  • Childhood neuropsychological deficits associated with adult obsessive-compulsive disorder. 
  • Children's and Parents' Ability to Tolerate Child Distress: Impact on Cognitive Behavioral Therapy for Pediatric Obsessive Compulsive Disorder. 
  • Circuit-selective striatal synaptic dysfunction in the Sapap3 knockout mouse model of obsessive-compulsive disorder. 
  • Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial. 
  • Cognitive behavioral therapy for pediatric obsessive-compulsive disorder: development of expert-level competence and implications for dissemination. 
  • Cognitive behavioral treatment for young children with obsessive-compulsive disorder. 
  • Comparison of lifetime psychiatric diagnoses in Premenstrual Syndrome Clinic and community samples. 
  • Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive-compulsive disorder that were non-responders to cognitive-behavior therapy: a randomized controlled trial. 
  • Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. 
  • D-amphetamine in obsessive-compulsive disorder 
  • Deep brain stimulation and ablation for obsessive compulsive disorder: evolution of contemporary indications, targets and techniques. 
  • Depressed adolescents and comorbid psychiatric disorders: are there differences in the presentation of depression? 
  • Development of a computer-based behavioral assessment of checking behavior in obsessive-compulsive disorder. 
  • Diagnostic Correlates of Nonsuicidal Self-Injury Disorder among Veterans with Psychiatric Disorders. 
  • Differential response to placebo among patients with social phobia, panic disorder, and obsessive-compulsive disorder. 
  • Distinct trajectories of long-term symptom severity in pediatric obsessive-compulsive disorder during and after stepped-care treatment. 
  • Early alliance, alliance ruptures, and symptom change in a nonrandomized trial of cognitive therapy for avoidant and obsessive-compulsive personality disorders. 
  • Early childhood OCD: preliminary findings from a family-based cognitive-behavioral approach. 
  • Effect of Experimental Manipulation of the Orbitofrontal Cortex on Short-Term Markers of Compulsive Behavior: A Theta Burst Stimulation Study. 
  • Elevated Autism Spectrum Disorder Traits in Young Children with OCD. 
  • Eye-tracking, attention and amphetamine challenge. 
  • Family-Based Treatment of Pediatric Obsessive-Compulsive Disorder: Clinical Considerations and Application. 
  • Family-based treatment of early childhood obsessive-compulsive disorder: the Pediatric Obsessive-Compulsive Disorder Treatment Study for Young Children (POTS Jr)--a randomized clinical trial. 
  • Fast track randomized controlled trial to prevent externalizing psychiatric disorders: findings from grades 3 to 9. 
  • Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders. 
  • Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison. 
  • Functional magnetic resonance imaging guided transcranial magnetic stimulation in obsessive-compulsive disorder. 
  • General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial. 
  • Genome-wide association study of obsessive-compulsive disorder. 
  • Glutamatergic dysfunction in OCD. 
  • High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial. 
  • How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. 
  • Increased Metabotropic Glutamate Receptor 5 Signaling Underlies Obsessive-Compulsive Disorder-like Behavioral and Striatal Circuit Abnormalities in Mice. 
  • Insight and treatment outcome in obsessive-compulsive disorder. 
  • Intractable seizures, compulsions, and coprolalia: a pediatric case study. 
  • Intrusive thoughts: linking spontaneous mind wandering and OCD symptomatology. 
  • MAO inhibitor therapy in trichotillomania associated with depression: case report. 
  • Modulation of motor cortex excitability in obsessive-compulsive disorder: an exploratory study on the relations of neurophysiology measures with clinical outcome. 
  • Multiple rare SAPAP3 missense variants in trichotillomania and OCD. 
  • Neuroimaging for psychotherapy research: current trends. 
  • Normal CSF oxytocin and NPY levels in OCD. 
  • OCD-Like behaviors caused by a neuropotentiating transgene targeted to cortical and limbic D1+ neurons. 
  • Obsessions and compulsions in the community: prevalence, interference, help-seeking, developmental stability, and co-occurring psychiatric conditions. 
  • Obsessive-compulsive disorder in a birth cohort of 18-year-olds: prevalence and predictors. 
  • Obsessive-compulsive disorder in callers to the Anxiety Disorders Association of America. 
  • One-Year Outcome for Responders of Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder. 
  • PDI-4A: an augmented provisional screening instrument assessing 5 additional common anxiety-related diagnoses in adult primary care patients. 
  • Potential fluoxetine chloride (Prozac) toxicity in a newborn. 
  • Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I). 
  • Predictors associated with improved cognitive-behavioral therapy outcome in pediatric obsessive-compulsive disorder. 
  • Predictors of parental accommodation in pediatric obsessive-compulsive disorder: findings from the Pediatric Obsessive-Compulsive Disorder Treatment Study (POTS) trial. 
  • Prevalence of anxiety disorders in men and women with established coronary heart disease. 
  • Psychiatric disorders. A rural/urban comparison. 
  • Psychosomatic symptoms in parents 2 years after the death of a child with cancer. 
  • Randomized sham-controlled trial of repetitive transcranial magnetic stimulation in treatment-resistant obsessive-compulsive disorder. 
  • Repetitive Transcranial Magnetic Stimulation of the Supplementary Motor Area in the treatment of Tourette Syndrome: report of two cases. 
  • Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS). 
  • Risk factors prospectively associated with adult obsessive-compulsive symptom dimensions and obsessive-compulsive disorder. 
  • SLITRK1 mutations in trichotillomania. 
  • Secondary outcomes from the pediatric obsessive compulsive disorder treatment study II. 
  • Specialty knowledge and competency standards for pharmacotherapy for pediatric obsessive-compulsive disorder. 
  • Still Struggling: characteristics of youth with OCD who are partial responders to medication treatment. 
  • Structural neural markers of response to cognitive behavioral therapy in pediatric obsessive-compulsive disorder. 
  • The effects of childhood parental death and divorce on six-month history of anxiety disorders. 
  • The impact of neuropsychological functioning on treatment outcome in pediatric obsessive-compulsive disorder. 
  • The pediatric obsessive-compulsive disorder treatment study: rationale, design, and methods. 
  • The relationship between restrictive and repetitive behaviors in individuals with autism and obsessive compulsive symptoms in parents. 
  • The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients. 
  • Tic-related obsessive-compulsive disorder (OCD): phenomenology and treatment outcome in the Pediatric OCD Treatment Study II. 
  • Tics Moderate Sertraline, but Not Cognitive-Behavior Therapy Response in Pediatric Obsessive-Compulsive Disorder Patients Who Do Not Respond to Cognitive-Behavior Therapy. 
  • Tourette's syndrome and the law. 
  • Treating Pediatric Anxiety: Initial Use of SSRIs and Other Antianxiety Prescription Medications. 
  • Trichotillomania--a review. 
• 

  Keywords of People

  • Calakos, Nicole, Lincoln Financial Group Distinguished Professor of Neurobiology, Duke Science & Society